Niagen Bioscience, Inc. (NAGE)

Niagen Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 27, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	404	406	108	125	256	297
Market Cap Growth	-3.38%	277.18%	-14.15%	-50.96%	-14.02%	15.84%
Enterprise Value	343	377	85	117	226	284
Last Close Price	5.05	5.30	1.43	1.68	3.74	4.80
PE Ratio	21.50	47.50	-	-	-	-
Forward PE	22.08	50.28	-	-	-	-
PS Ratio	3.24	4.08	1.29	1.74	3.79	5.02
PB Ratio	5.71	8.81	3.78	4.37	8.06	18.11
P/TBV Ratio	5.74	8.88	3.85	4.48	8.29	19.39
P/FCF Ratio	19.12	33.99	15.45	-	-	-
P/OCF Ratio	18.89	33.54	15.13	-	-	-
EV/Sales Ratio	2.75	3.78	1.01	1.62	3.35	4.79
EV/EBITDA Ratio	17.10	44.12	-	-	-	-
EV/EBIT Ratio	17.79	48.76	-	-	-	-
EV/FCF Ratio	16.24	31.54	12.17	-	-	-
Debt / Equity Ratio	0.04	0.06	0.12	0.15	0.15	0.10
Debt / EBITDA Ratio	0.14	0.27	-	-	-	-
Debt / FCF Ratio	0.14	0.22	0.47	-	-	-
Net Debt / Equity Ratio	-0.86	-0.91	-0.84	-0.56	-0.73	-0.90
Net Debt / EBITDA Ratio	-3.04	-4.90	5.23	0.91	0.90	0.79
Net Debt / FCF Ratio	-2.89	-3.50	-3.43	1.04	0.95	1.39
Asset Turnover	1.61	1.62	1.53	1.29	1.40	1.51
Inventory Turnover	3.07	3.21	2.25	2.07	2.05	2.07
Quick Ratio	3.23	2.96	1.57	1.61	1.89	1.17
Current Ratio	4.12	3.57	2.40	2.61	2.78	1.96
Return on Equity (ROE)	38.90%	22.94%	-17.29%	-54.77%	-112.68%	-108.09%
Return on Assets (ROA)	15.60%	7.84%	-6.42%	-20.81%	-35.18%	-31.57%
Return on Invested Capital (ROIC)	221.46%	169.60%	-65.11%	-176.99%	-542.87%	-776.15%
Return on Capital Employed (ROCE)	25.60%	15.40%	-16.30%	-51.50%	-67.30%	-90.70%
Earnings Yield	5.05%	2.10%	-4.59%	-13.19%	-10.61%	-6.70%
FCF Yield	5.23%	2.94%	6.47%	-12.31%	-9.61%	-3.60%
Buyback Yield / Dilution	-10.80%	-4.19%	-7.54%	-3.79%	-10.02%	-7.03%

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q